Tinea versicolor treatment market overview and analysis by diagnosis, treatment, end user- global forecast till 2030. It has been determined that the global market for tinea versicolor treatments is expanding moderately, and more growth is anticipated in the near future. A frequent yeast infection of the skin is tinea versicolor. In tropical regions, the prevalence rate is higher, and summertime is when it occurs more frequently. The rising incidence of various skin conditions is a major driver of market expansion. The global tinea versicolor market is also being driven by some other significant factors, including rising awareness, new drug development, clinical studies, and approvals, as well as rising demand from emerging regions in Asia and South America.
The market for Tinea Versicolor treatment is expected to reach USD 374.6 million by 2030 which is a projected CAGR of 9.2%.
Major players in Tinea Versicolor treatment market:
There are plenty of large and small market players which operate in this market: Astellas Pharma US, Inc. (Japan), Bayer AG (German), Enzon Pharmaceuticals, Inc. (US), Galderma S.A. (Switzerland), Gilead (US), Novartis AG (Switzerland), Pfizer Inc. (US), Taro Pharmaceutical Industries Ltd. (US), Teva Pharmaceutical Industries Ltd. (Israel), Valeant (Canada), and others.
Segmentation:
Global tinea versicolor treatment size has been segmented on the basis of diagnosis, treatments and end user.
On the basis of diagnosis which comprise physical exam, imaging tests, and others. Imaging test is sub-segmented into wood lamp (black light) examination, microscopy using Potassium Hydroxide (KOH), fungal culture, skin biopsy, and others. Skin biopsy is sub-segmented into shave biopsy, punch biopsy, excisional biopsy, and others.
On the basis of treatments, the market has been segmented into antifungal shampoos, antifungal creams, drugs, and others. Antifungal shampoos are sub-segmented into selenium sulfide (selsun) 2.5 percent shampoo, ciclopirox (loprox, penlac) shampoo, ketoconazole (ketoconazole, nizoral, others) shampoo, and others. Antifungal creams are sub-segmented into Selenium sulfide (Selsun) 2.5 percent lotion, Ciclopirox (Loprox, Penlac) cream or gel, Ketoconazole (Ketoconazole, Nizoral, others) cream or gel, and others. Drugs are further sub-segmented into fluconazole (diflucan) tablets or oral solution, and others.
On the basis of end user, it is segmented into dermatology hospital and clinics, medical research centers, academic institutes, and others.
Regional Analysis
Considering the global scenario of the tinea versicolor treatment market, there are four main regions, America, Europe, Asia Pacific, and Middle East and Africa. The Americas is holding largest market share. The Americas mainly include North America and South America. North America is very important and highest revenue generator market for tinea versicolor treatment. Asia Pacific is second largest and fastest growing market.
Some major factors like increasing awareness of the disease, developing healthcare sector, and rising healthcare expenditure are driving the growth for Asia Pacific tinea versicolor treatment market. Europe tinea versicolor treatment is also growing significantly. Germany, UK, and France are the major markets while Eastern European tinea versicolor treatment market is also growing. Middle East Africa tinea versicolor treatment market is expected to have limited growth mainly due to lack of awareness of the disease, and limited access to the healthcare facilities. Due to developed healthcare infrastructure and high expenditure on healthcare, Middle East is dominating region as compared to Africa.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
